医学
内科学
化疗
拓扑替康
置信区间
卵巢癌
优势比
肿瘤科
随机化
无进展生存期
随机对照试验
卡铂
外科
胃肠病学
癌症
顺铂
作者
Kathleen N. Moore,Antoine Angelergues,Gottfried E. Konecny,Yolanda García García,Susana Banerjee,Domenica Lorusso,Jung‐Yun Lee,John W. Moroney,Nicoletta Colombo,A. Roszak,Jacqueline M. Tromp,Tashanna Myers,Jeong‐Won Lee,Mario Beiner,Casey Cosgrove,David Cibula,Lainie P. Martin,Renaud Sabatier,Joseph Buscema,Purificación Estévez-García
标识
DOI：10.1056/nejmoa2309169
摘要
Among participants with platinum-resistant, FRα-positive ovarian cancer, treatment with MIRV showed a significant benefit over chemotherapy with respect to progression-free and overall survival and objective response. (Funded by ImmunoGen; MIRASOL ClinicalTrials.gov number, NCT04209855.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
浮游
BowieHuang
shhoing
JiahaoRao
eric888
无极微光
含糊的尔槐
Linos
七慕凉
blackddl
aldehyde
皮皮
发文章
Criminology34
nPgA2o
子车茗
hbit
裂冰
GPTea
Yini
小青椒
123a
666
mmyhn
皖公网安备34019202002308
